Related Experiment Video
Updated: May 23, 2026

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
Published on: January 23, 2026
Administration of vincristine in a patient with Machado-Joseph disease
Anna Colpo1, Frederick H Wilson, Valentina Nardi
1Department of Medicine, Haematology and Clinical Immunology, University of Padua School of Medicine, Padua, Italy.
Abstract:
Chemotherapy-induced peripheral neurotoxicity is a major problem because it represents the dose-limiting side effect of a significant number of antineoplastic drugs, such as vinca alkaloids. Hereditary neuropathies usually predispose to severe vincristine neurotoxicity. Here, we report the case of a 56-year-old man with Machado-Joseph disease, also known as spinocerebellar ataxia type 3, treated with a vinca alkaloid without exacerbation of neurological symptoms.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs that Destabilize Microtubules
Drug Dosing: Geriatric Patients
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Treatment Resistant Cancers
Dosage Regimen: Individualization